New Ray Medicine International Holding Limited (HKG:6108)

HKG:6108 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 27, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	47	75	84	159	711	711
Market Cap Growth	-34.42%	-10.00%	-47.37%	-77.65%	-	-
Enterprise Value	-5	-12	-28	9	644	612
Last Close Price	0.23	0.45	0.50	0.95	4.25	4.25
PS Ratio	0.39	0.80	1.67	1.77	2.12	5.33
PB Ratio	0.11	0.16	0.17	0.30	1.12	1.17
P/TBV Ratio	0.11	0.16	0.17	0.31	1.14	1.19
EV/Sales Ratio	-	-	-	0.10	1.92	4.59
EV/FCF Ratio	0.21	-	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.00	0.00	0.02	0.00
Asset Turnover	0.26	0.19	0.10	0.15	0.51	0.20
Inventory Turnover	6.99	3.73	1.17	1.48	3.30	3.97
Quick Ratio	7.06	4.76	29.73	24.58	11.05	2.51
Current Ratio	19.13	12.01	68.08	51.47	24.83	10.57
Return on Equity (ROE)	-7.70%	-6.52%	-4.41%	-13.46%	-0.46%	-11.06%
Return on Assets (ROA)	-5.40%	-4.76%	-2.60%	-7.63%	-0.67%	-4.22%
Return on Invested Capital (ROIC)	-10.93%	-9.64%	-5.72%	-16.92%	-1.36%	-8.08%
Return on Capital Employed (ROCE)	-9.50%	-7.90%	-4.40%	-13.80%	-1.10%	-7.30%
Earnings Yield	-72.92%	-41.22%	-26.52%	-49.08%	-0.40%	-9.81%
FCF Yield	-46.74%	-7.16%	-54.37%	-5.68%	-8.23%	-4.48%
Buyback Yield / Dilution	81.82%	-	-	-	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.